SS Innovations International, Inc.SSIIEarnings & Financial Report
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
Revenue
$3.6M
Gross Profit
$728.2K
Operating Profit
$-9.8M
Net Profit
$-9.8M
Gross Margin
20.0%
Operating Margin
-270.3%
Net Margin
-270.5%
YoY Growth
882.8%
EPS
$-0.06
SS Innovations International, Inc. Q1 FY2024 Financial Summary
SS Innovations International, Inc. reported revenue of $3.6M (up 882.8% YoY) for Q1 FY2024, with a net profit of $-9.8M (down 649.6% YoY) (-270.5% margin). Cost of goods sold was $2.9M, operating expenses totaled $10.6M.
Key Financial Metrics
| Total Revenue | $3.6M |
|---|---|
| Net Profit | $-9.8M |
| Gross Margin | 20.0% |
| Operating Margin | -270.3% |
| Report Period | Q1 FY2024 |
SS Innovations International, Inc. Annual Revenue by Year
SS Innovations International, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $42.5M).
| Year | Annual Revenue |
|---|---|
| 2025 | $42.5M |
| 2024 | $20.6M |
| 2023 | $5.9M |
SS Innovations International, Inc. Quarterly Revenue & Net Profit History
SS Innovations International, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $14.5M | +79.1% | $-2.5M | -17.0% |
| Q3 FY2025 | $12.8M | +192.5% | $-3.7M | -29.0% |
| Q2 FY2025 | $10.0M | +121.8% | $-256.7K | -2.6% |
| Q1 FY2025 | $5.1M | +40.8% | $-5.7M | -111.0% |
| Q4 FY2024 | $8.1M | +469.0% | $-1.9M | -23.7% |
| Q3 FY2024 | $4.4M | +100.6% | $-3.2M | -74.0% |
| Q2 FY2024 | $4.5M | +138.3% | $-4.1M | -91.8% |
| Q1 FY2024 | $3.6M | +882.8% | $-9.8M | -270.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6M | $4.5M | $4.4M | $8.1M | $5.1M | $10.0M | $12.8M | $14.5M |
| YoY Growth | 882.8% | 138.3% | 100.6% | 469.0% | 40.8% | 121.8% | 192.5% | 79.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $35.2M | $35.7M | $39.0M | $42.4M | $63.5M | $70.0M | $69.6M | $74.2M |
| Liabilities | $18.5M | $20.9M | $25.3M | $28.9M | $22.9M | $28.0M | $29.9M | $36.0M |
| Equity | $16.7M | $14.8M | $13.7M | $13.5M | $40.6M | $42.0M | $39.6M | $38.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.7M | $-1.0M | $-2.5M | $-3.3M | $-6.1M | $-3.5M | $-7.5M | $-1.5M |